Navigation Links
Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Significant Improvements in Levels of Carcinogenic 1,4-dioxane

But New Study Indicates Many Products Mislabeled as 'Natural' and 'Organic' Should Still Have Cancer Warning

ANAHEIM, Calif., Feb. 27 /PRNewswire-USNewswire/ -- On Friday, March 6, 2009 a follow-up study on 1,4-dioxane contamination in consumer products commissioned by the Organic Consumers Association (OCA), a watchdog group with over 500,000 members, and overseen by environmental health consumer advocate David Steinman (author of The Safe Shopper's Bible), will be released. The study analyzes leading major "natural" and "organic" as well as conventional brand shampoos, body washes, dish soap and other personal care and cleaning products which come in contact with human skin for the presence of the undisclosed carcinogenic petrochemical contaminant 1,4-dioxane. The independent third-party laboratory, Bodycote Testing Group, known for rigorous testing and chain-of-custody protocols, performed all testing.

The results indicate significant improvement for products from sixteen major brands coinciding with public announcements of test results beginning in February 2007, and lawsuits from the California Attorney General's office in June 2008 (following release of test results in March 2008). The OCA pledges to keep up the pressure until every brand claiming to be "natural" or "organic" removes 1,4-dioxane and other carcinogenic or problematic chemicals from their products.

WHO: David Steinman, Environmental Health Consumer Advocate

Ronnie Cummins, Executive Director, Organic Consumers Association

WHAT: Press conference on 1,4-dioxane in "Natural" and "Organic" Personal Care and Household Cleaning Products

WHEN: Friday, March 6, 2009, 9:00 a.m. PST to coincide with the Natural Products Expo West

WHERE: Anaheim Hilton, 777 Convention Way, Anaheim CA, 92802, Coronado Room 4th Floor


Ethoxylation, a cheap shortcut companies use to provide mildness to harsh cleaning ingredients, requires the use of the cancer-causing petrochemical ethylene oxide, which generates 1,4-dioxane as a byproduct. 1,4-dioxane is considered a chemical "known to the State of California to cause cancer" under proposition 65, and has no place in "natural" or "organic" branded personal care products. 1,4-dioxane is also suspected as a kidney toxicant, neurotoxicant and respiratory toxicant, among others, according to the California EPA, and is a significant groundwater contaminant. While previous studies have revealed the presence of 1,4-dioxane in "natural" and conventional products, this latest study shows the toxin is being significantly reduced as brands reformulate.

Further Resources

OCA Facts about 1,4-dioxane:

2008 Press Release and Results:

Lawsuits from the CA Attorney General's office:

Campaign for Safe Cosmetics:

Environmental Working Group:

SOURCE Organic Consumers Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. National Coalition for Cancer Survivorship, UCLA, WellPoint, and Genentech Launch Initiative to Provide Coordinated Follow-Up Care for People Surviving Cancer
2. New Research Shows Dental Implants Require Significantly More Follow-Up Treatment Than Root Canals
3. MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
4. "PEACE of Heart" Campaign Comes to Metro Washington to Help Fight Heart Disease Epidemic among Minorities : Hallmark of Campaign's Health Screening Events Is Personalized Follow-Up
5. Many colorectal cancer survivors do not receive recommended follow-up care
6. Blacks, Hispanics less likely than whites to receive follow-up radiation for early breast cancer
7. More patients with drug-coated cardiac stents survive, avoid costly follow-up procedures
8. Incidental adrenal masses commonly seen on CT are usually benign; no follow-up needed
9. 6-month follow-up diagnostic mammograms recommended for women with probably benign lesions
10. Millions of Euros could be saved if breast cancer follow-ups were led by specialist nurses
11. WHI follow-up study: Risks of long-term hormone therapy continue to outweigh benefits
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: